Quality of life (QoL) with fulvestrant (FUL)/palbociclib (PAL) versus FUL/placebo (PBO) in postmenopausal women with hormone receptor (HR)+/HER2-endocrine sensitive advanced breast cancer (ABC): Results from GEICAM/2014-12 (FLIPPER) study
No Thumbnail Available
Identifiers
Date
2021-05-08
Authors
Tibau, A.
Martinez, M. T.
Ramos, M.
De la Cruz-Merino, L.
Santaballa, A.
O'Connor, M.
Martinez-Janez, N.
Moreno, F.
Fernandez-Perez, I.
Virizuela, J. A.
Advisors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Metrics
Export
